Safety, Pharmacokinetics and Pharmacodynamics Study of HL-032 in Healthy Male Volunteers

NCT01440686 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Growth Hormone Deficiency

Interventions

DRUG: Somatropin
DRUG: Placebo

Sponsor

HanAll BioPharma Co., Ltd.